Skip to content

Home
About Us
Log In

News
- All News
- Finance
- Treatment
- People
- Research
Videos
Treatments
Clinical Trials
Access Programs
- About Access Programs
Diseases
Events
Networks
Research

Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field

Email Marketing Services by Benchmark

Generate RSS

Select number of items

Home
/
Treatment
/
Rintatolimod

Rintatolimod

	Rintatolimod
Trade Name
Orphan Indication	Ebola
EU Market Approval	EU
EU Designation Date	2015-04-24 00:00:00
Sponsor	NV Hemispherx BioPharma Europe

Related Treatment

Ranpirnase
Three chimeric human/murine monoclonal antibodies against the Ebola (Z
Three human IgG1 mAbs (REGN3470, REGN3471, and REGN3479) directed agai
Monovalent replication-incompetent adenovirus serotype 26 (Ad26) vacci
Aphidicolin

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

Your Name (required)

Your Email (required)

Your Message

Copyright © 2024 CheckOrphan.

Developed by:

Developed by: WebOptimalSolutions Powered by: